EIP Pharma to initiate in 2Q 2023 a Phase 2b clinical study, funded in part by a $21 million grant from the National Institute of Aging
The requirement of blood in India is estimated to be 8.5 million to 10 million units/per year, whereas the available supply is only 7.4 million units/per year
Celerity Pharmaceuticals uses Biocon Biologics’ insulin drug substance to develop the product
Ivenix selected Tritan MXF for the pump exterior because of its excellent chemical resistance and durability in the face of the aggressive disinfection protocols needed to prevent the spread of healthcare-associated infections
This Orphan Drug Designation from the USFDA underlines the urgent medical need to develop a therapy for sickle cell disease
A final decision on the updated application is expected in the first half of 2026, while intravenous (IV) Saphnelo remains commercially available
The Union Budget 2026–27 accords strong priority to the upgradation and expansion of healthcare infrastructure and medical education
This deal marks a major step for Alteogen as it pushes its Hybrozyme platform deeper into the oncology market
ATEC secures exclusive U.S. commercial rights to Theradaptive’s OsteoAdapt osteoinductive bone graft, currently in clinical trials for spinal and dental applications
The feature will be available across all Max Healthcare facilities, offering patients consistent and convenient access to services nationwide
Subscribe To Our Newsletter & Stay Updated
